Our people

Latest

Neuroblastoma Australia Responds to Federal Budget Announcement

Neuroblastoma Australia is extremely disappointed the Federal Budget did not include specific funding for CAR-T Cell treatment for solid tumours - it’s a devastating omission for Australian children diagnosed with neuroblastoma.
Oaten's | Raising funds for research into neuroblastoma

I'm fundraising for Neuroblastoma Australia, to raise funds for vital research into better, kinder and more effective treatments for the children's cancer neuroblastoma. Please show your support by donating via this page.
A Wish Come True for Logan

Little legend, Logan, was diagnosed with neuroblastoma as a baby. Recently, Collingwood's Nick Daicos made Logan's dream come true by running out onto the pitch with him for Daicos' 100th AFL appearance.
Our Story

Neuroblastoma takes the lives of more children under five than any other cancer. Help us fund new research to find a cure within our lifetime and save toddlers' lives.

Prof. Gudrun Schleiermacher

Gudrun Schleiermacher is a pediatric oncologist and researcher who works as a physician-scientist at Institut Curie, Paris, France, where she is Delegate Director for Translational Research of the SIREDO Integrated Pediatric Oncology Center, a group leader of the RTOP (Translational Research in Pediatric Oncology) team of the U1300 INSERM research unit
Jake Rose

Jake Rose is a Chartered Accountant and Justice of the Peace with extensive experience in financial operations, as well as business systems and processes.
Nita Arora-Parkes

Nita is founder and Director of Groupcpo; a platform for small businesses and start-ups to find, buy and sell the tools and services they need to grow and scale their business. Nita has over 20 years’ experience as a technology and procurement executive, managing strategic partnerships and vendor negotiations with a global team.
Lucy Jones

Lucy Jones is the CEO of Neuroblastoma and mother to Sienna and Jamie Hoffmann. Lucy is focused on driving change in survival rates through more research, having tragically lost her daughter Sienna to the illness in 2010.
Rochelle Yates

Rochelle is a mother of two, and Chairman of a global logistics company where she specialises in marketing. Rochelle's career includes vast experience in events and promotions and she has brought this skill to help coordinate numerous fundraising events and activities for Neuroblastoma Australia.
Jane Price

Jane Price holds a Bachelor of Arts and a Bachelor of Laws. She is a small business owner, running her own immigration consultancy business, which she has grown in a few short years into a thriving practice with a couple of employees. Jane is lucky enough to have a “pigeon-pair” of children (aged 11 & 14) and was also privileged to know Sienna Hoffman.
Tim Bateman

Director, The Rockpool People and Parlour Capital, Tim Bateman is a father of three and brings a wealth of financial services experience with him. After completing an Economics and Finance Degree, Tim spent 13 years in London working in the derivatives markets. He has worked across stock broking, investment banking, and finance broking in Australasia and the United Kingdom. Among other interests, Tim runs a boutique finance broking firm and was also a franchise owner for Little Kickers, kids’
Dr Louise Causer

Louise is a medical epidemiologist and lecturer currently based at The Kirby Institute, UNSW Australia and has worked internationally both in clinical and research settings across a number of fields. Having trained and working in a highly academic setting for the past decade, Louise has direct experience and key insight into the research setting in Australia and internationally.
Dr. Steve DuBois

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.
Prof. Juliet Gray

Professor Juliet Gray is an Associate Professor in Paediatric Oncology at the Cancer Immunology Centre, University of Southampton. She leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials.

What is neuroblastoma?
Donate today

One in two children with aggressive neuroblastoma will not survive. Neuroblastoma is the number one toddler cancer. We need your help to find effective treatments. Donate today to support world class Australian research into developing less toxic, more effective treatments, with the ultimate goal of finding a cure. Donate as an individual or business and receive a tax-deductible receipt for all donations over $2.
Detection, diagnosis & staging

Know about symptoms of neuroblastoma, detection, diagnosis and different stages of neuroblastoma childhood cancer.
How common is neuroblastoma?
How dangerous is neuroblastoma?
Our Story

Neuroblastoma takes the lives of more children under five than any other cancer. Help us fund new research to find a cure within our lifetime and save toddlers' lives.
How is it diagnosed?
Why does this cancer form?
Golf2Cure 2025

Our 2025 charity golf day, Golf2Cure, will take place on Thursday, June 26 at the prestigious Lakes Golf Club at Eastlakes, Sydney. The aim of the day is to have fun, increase awareness of neuroblastoma, and to raise funds for research into this devastating childhood cancer so we can find treatments that are more effective and less toxic.
Key Statistics

Know key statistics about the childhood cancer, neuroblastoma. Neuroblastoma is the most common solid tumour of childhood and its treatment. Most neuroblastomas, made up of cells found in nerve tissues of the body, start in the adrenal glands.